Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Legrand, C.
Right arrow Articles by Lawler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Legrand, C.
Right arrow Articles by Lawler, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation

C Legrand, V Thibert, V Dubernard, B Begault and J Lawler

Unite 150 INSERM, Hopital Lariboisiere/Hopital St Louis, Paris, France.

We have investigated the molecular requirements for thrombospondin (TSP) to bind to the platelet surface and to support the subsequent secretion-dependent platelet aggregation. For this, we used two distinct murine monoclonal antibodies (MoAbs), designated MAI and MAII, raised against human platelet TSP, and three polyclonal antibodies, designated R3, R6, and R5, directed against fusion proteins containing the type 1 (Gly 385-Ile 522), type 2 (Pro 559-Ile 669), and type 3 (Asp 784-Val 932) repeating sequences, respectively. Among them, R5 and R6, but not R3, inhibited thrombin-induced aggregation of washed platelets and the concomitant secretion of serotonin. These antibodies, however, did not inhibit the expression of TSP on thrombin-activated platelets, as measured by the binding of a radiolabeled MoAb to TSP, suggesting that they may inhibit platelet aggregation by interfering with a physiologic event subsequent to TSP binding. In contrast, MoAb MAII, which reacts with an epitope located within the heparin-binding domain of TSP, inhibited both TSP surface expression and platelet aggregation/secretion induced by thrombin. In addition, this MoAb inhibited in a dose-dependent manner (IC50 approximately 0.5 mumol/L) the interaction of 125I-TSP with immobilized fibrinogen and platelet glycoprotein IV, both potential physiologic receptors for TSP on thrombin-activated platelets. These results indicate that the interaction of TSP with the surface of activated platelets can be modulated at the level of a specific epitope located within the amino terminal heparin-binding domain of the molecule. Thus, selective inhibition of the platelet/TSP interaction may represent an alternative approach to the inhibition of platelet aggregation.

Volume 79, Issue 8, pp. 1995-2003, 04/15/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Bonnefoy, K. Daenens, H. B. Feys, R. De Vos, P. Vandervoort, J. Vermylen, J. Lawler, and M. F. Hoylaerts
Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13
Blood, February 1, 2006; 107(3): 955 - 964.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Saumet, M. B. Slimane, M. Lanotte, J. Lawler, and V. Dubernard
Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/{alpha}v{beta}3 in promyelocytic leukemia NB4 cells
Blood, July 15, 2005; 106(2): 658 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Brittain, J. Han, K. I. Ataga, E. P. Orringer, and L. V. Parise
Mechanism of CD47-induced {alpha}4{beta}1 Integrin Activation and Adhesion in Sickle Reticulocytes
J. Biol. Chem., October 8, 2004; 279(41): 42393 - 42402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. V. Narizhneva, V. J. Byers-Ward, M. J. Quinn, F. J. Zidar, E. F. Plow, E. J. Topol, and T. V. Byzova
Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction
J. Biol. Chem., May 14, 2004; 279(20): 21651 - 21657.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-M. Miao, W. Lin Seng, M. Duquette, P. Lawler, C. Laus, and J. Lawler
Thrombospondin-1 Type 1 Repeat Recombinant Proteins Inhibit Tumor Growth through Transforming Growth Factor-{beta}-dependent and -independent Mechanisms
Cancer Res., November 1, 2001; 61(21): 7830 - 7839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. C. Krutzsch, B. J. Choe, J. M. Sipes, N.-h. Guo, and D. D. Roberts
Identification of an alpha 3beta 1 Integrin Recognition Sequence in Thrombospondin-1
J. Biol. Chem., August 20, 1999; 274(34): 24080 - 24086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Sipes, H. C. Krutzsch, J. Lawler, and D. D. Roberts
Cooperation between Thrombospondin-1 Type 1 Repeat Peptides and alpha vbeta 3 Integrin Ligands to Promote Melanoma Cell Spreading and Focal Adhesion Kinase Phosphorylation
J. Biol. Chem., August 6, 1999; 274(32): 22755 - 22762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Panetti, B. J. Kudryk, and D. F. Mosher
Interaction of Recombinant Procollagen and Properdin Modules of Thrombospondin-1 with Heparin and Fibrinogen/Fibrin
J. Biol. Chem., January 1, 1999; 274(1): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. Dubernard, B. B. Arbeille, M. B. Lemesle, and C. Legrand
Evidence for an {alpha}-Granular Pool of the Cytoskeletal Protein {alpha}-Actinin in Human Platelets That Redistributes With the Adhesive Glycoprotein Thrombospondin-1 During the Exocytotic Process
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2293 - 2305.
[Abstract] [Full Text]


Home page
BloodHome page
G. A. Barabino, R. J. Wise, V. A. Woodbury, B. Zhang, K. A. Bridges, R. P. Hebbel, J. Lawler, and B. M. Ewenstein
Inhibition of Sickle Erythrocyte Adhesion to Immobilized Thrombospondin by von Willebrand Factor Under Dynamic Flow Conditions
Blood, April 1, 1997; 89(7): 2560 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Gawaz, I. Ott, A. J. Reininger, U. Heinzmann, and F.-J. Neumann
Agglutination of Isolated Platelet Membranes
Arterioscler. Thromb. Vasc. Biol., May 1, 1996; 16(5): 621 - 627.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Hofsteenge, K. G. Huwiler, B. Macek, D. Hess, J. Lawler, D. F. Mosher, and J. Peter-Katalinic
C-Mannosylation and O-Fucosylation of the Thrombospondin Type 1 Module
J. Biol. Chem., February 23, 2001; 276(9): 6485 - 6498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bonnefoy, R. Hantgan, C. Legrand, and M. M. Frojmovic
A Model of Platelet Aggregation Involving Multiple Interactions of Thrombospondin-1, Fibrinogen, and GPIIbIIIa Receptor
J. Biol. Chem., February 16, 2001; 276(8): 5605 - 5612.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020